Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01049165 · ClinicalTrials.gov registry record · Phase 1
Single Ascending Dose (BMS-813160) Study
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 70
- Enrollment target
NCT01049165 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 70 participants.
The verdict
NCT01049165, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 70 participants
- Enrollment target
Study Summary
The primary purpose of this study is to evaluate the safety and tolerability of single oral doses of BMS-813160 in healthy subjects
Interventions
- DRUG BMS-813160
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01049165
The ClinicalTrials.gov registry entry for NCT01049165 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BMS-813160 is the first listed.
NCT01049165 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01049165 about?
NCT01049165 is a clinical study titled "Single Ascending Dose (BMS-813160) Study". The primary purpose of this study is to evaluate the safety and tolerability of single oral doses of BMS-813160 in healthy subjects
What is the current status of trial NCT01049165?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 70 participants. The study started on 2010-02. Estimated completion is 2010-11.
What interventions are being tested in trial NCT01049165?
The interventions under investigation include: BMS-813160 (DRUG).
Who is sponsoring clinical trial NCT01049165?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.